Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Relapsing Fever | 1 | 2020 | 25 | 0.720 |
Why?
|
| Ticks | 1 | 2020 | 71 | 0.710 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2019 | 1757 | 0.700 |
Why?
|
| Plasma Gases | 1 | 2017 | 12 | 0.560 |
Why?
|
| Deoxycytidine | 3 | 2018 | 887 | 0.550 |
Why?
|
| Mouth Neoplasms | 3 | 2014 | 597 | 0.460 |
Why?
|
| Exosomes | 1 | 2018 | 422 | 0.440 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 559 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 5 | 2018 | 5446 | 0.430 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 5341 | 0.420 |
Why?
|
| Carcinoma, Adenoid Cystic | 4 | 2015 | 263 | 0.390 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2015 | 493 | 0.390 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 6395 | 0.330 |
Why?
|
| MicroRNAs | 2 | 2018 | 3803 | 0.240 |
Why?
|
| Neck Dissection | 3 | 2014 | 201 | 0.230 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3603 | 0.220 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2019 | 646 | 0.200 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2020 | 113 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 4 | 2014 | 2931 | 0.160 |
Why?
|
| Collagenases | 1 | 2019 | 221 | 0.160 |
Why?
|
| Leukocyte Elastase | 1 | 2019 | 114 | 0.160 |
Why?
|
| Doxycycline | 1 | 2020 | 349 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2015 | 4058 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2017 | 228 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 551 | 0.140 |
Why?
|
| Macrophages, Peritoneal | 1 | 2018 | 244 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5863 | 0.140 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 17140 | 0.130 |
Why?
|
| Tumor Microenvironment | 3 | 2019 | 3948 | 0.130 |
Why?
|
| Ribonucleotide Reductases | 1 | 2015 | 75 | 0.120 |
Why?
|
| Biomedical Engineering | 1 | 2017 | 286 | 0.120 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2014 | 66 | 0.120 |
Why?
|
| Cellulose, Oxidized | 1 | 2013 | 12 | 0.110 |
Why?
|
| Nomograms | 1 | 2015 | 236 | 0.110 |
Why?
|
| Nervous System | 1 | 2017 | 544 | 0.110 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2014 | 133 | 0.110 |
Why?
|
| Status Epilepticus | 1 | 2019 | 463 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2018 | 1207 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2014 | 278 | 0.110 |
Why?
|
| Hemostasis, Surgical | 1 | 2013 | 128 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13676 | 0.100 |
Why?
|
| Quality of Life | 1 | 2014 | 13490 | 0.100 |
Why?
|
| Lymph Nodes | 2 | 2014 | 3474 | 0.100 |
Why?
|
| Methotrexate | 1 | 2019 | 1721 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 249 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18349 | 0.090 |
Why?
|
| Fever | 1 | 2019 | 1614 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2019 | 1397 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2253 | 0.090 |
Why?
|
| Thyroidectomy | 2 | 2014 | 913 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2014 | 514 | 0.090 |
Why?
|
| Neutrophils | 2 | 2023 | 3786 | 0.090 |
Why?
|
| Hemostatics | 1 | 2013 | 246 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 22379 | 0.090 |
Why?
|
| Macrophages | 2 | 2017 | 5799 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2014 | 467 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 3620 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2019 | 1554 | 0.080 |
Why?
|
| Neck | 1 | 2014 | 736 | 0.080 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2014 | 709 | 0.080 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 419 | 0.080 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 642 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2018 | 4146 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1363 | 0.080 |
Why?
|
| Equipment Design | 1 | 2017 | 3522 | 0.080 |
Why?
|
| Mice | 8 | 2019 | 82029 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2019 | 1985 | 0.070 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 11244 | 0.070 |
Why?
|
| Animals | 9 | 2020 | 169246 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1350 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9419 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 2008 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14488 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3728 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39348 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2015 | 59629 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 2665 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 1640 | 0.050 |
Why?
|
| Prognosis | 5 | 2014 | 30010 | 0.050 |
Why?
|
| Apoptosis | 2 | 2017 | 9523 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10101 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 13671 | 0.050 |
Why?
|
| Israel | 2 | 2015 | 726 | 0.050 |
Why?
|
| Humans | 23 | 2023 | 768166 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3390 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5717 | 0.050 |
Why?
|
| Algorithms | 2 | 2019 | 14164 | 0.050 |
Why?
|
| Young Adult | 7 | 2015 | 60066 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 2360 | 0.040 |
Why?
|
| Survival Rate | 4 | 2014 | 12840 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2023 | 960 | 0.040 |
Why?
|
| Glioma | 1 | 2014 | 3503 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8647 | 0.040 |
Why?
|
| British Columbia | 1 | 2019 | 240 | 0.040 |
Why?
|
| Middle Aged | 11 | 2019 | 223492 | 0.040 |
Why?
|
| International Cooperation | 2 | 2015 | 1436 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 571 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 1514 | 0.040 |
Why?
|
| Adult | 11 | 2019 | 223646 | 0.040 |
Why?
|
| Aged | 9 | 2015 | 171504 | 0.030 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 1996 | 50 | 0.030 |
Why?
|
| Peroxidase | 1 | 2019 | 610 | 0.030 |
Why?
|
| Female | 13 | 2019 | 397192 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 2914 | 0.030 |
Why?
|
| Liposomes | 1 | 2019 | 790 | 0.030 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2014 | 13 | 0.030 |
Why?
|
| Male | 12 | 2019 | 364719 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 6847 | 0.030 |
Why?
|
| Thyroid Cartilage | 1 | 2014 | 46 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 22371 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2019 | 81762 | 0.030 |
Why?
|
| Adolescent | 6 | 2019 | 89169 | 0.030 |
Why?
|
| Abdominal Injuries | 1 | 1996 | 362 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 521 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 4912 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 9118 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1512 | 0.030 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2013 | 115 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2013 | 156 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2019 | 911 | 0.030 |
Why?
|
| International Agencies | 1 | 2013 | 244 | 0.030 |
Why?
|
| Pancreas | 1 | 2019 | 1700 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 446 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2015 | 23645 | 0.020 |
Why?
|
| Fibrosis | 1 | 2019 | 2080 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2019 | 1733 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21206 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 1738 | 0.020 |
Why?
|
| ROC Curve | 1 | 2019 | 3628 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12077 | 0.020 |
Why?
|
| Collagen | 1 | 2019 | 2643 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15454 | 0.020 |
Why?
|
| Mouth | 1 | 2013 | 383 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2013 | 427 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1996 | 807 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8741 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1587 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20227 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2000 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6124 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1140 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 1135 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 2603 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 1791 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5315 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18412 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2661 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2565 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10266 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11095 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3611 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6340 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8317 | 0.010 |
Why?
|
| Patient Selection | 1 | 2015 | 4260 | 0.010 |
Why?
|
| Time Factors | 2 | 2015 | 40218 | 0.010 |
Why?
|
| Child | 2 | 2023 | 80917 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6526 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5210 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6983 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10632 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10760 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10474 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2015 | 65371 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6498 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7951 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 13014 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74944 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14783 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 42669 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 21538 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 24315 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1996 | 520 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 54926 | 0.000 |
Why?
|
| Liver | 1 | 1996 | 7577 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20760 | 0.000 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_